SEC 13F Intelligence

Artia Global Partners LP / AXSM

Artia Global Partners LP’s Axsome Therapeutics Inc. Position

Does Artia Global Partners LP own Axsome Therapeutics Inc. (AXSM)? Not currently — the last reported position was 87.8K shares worth $8M in Q3 2024; the fund’s latest 13F (Q1 2026) no longer reports it.

Position Value
$8M
Q3 2024
Shares
87.8K
% of Portfolio
+2.15%
Quarters Held
6
position exited

Position History AXSM

Reported value by quarter
Q2 ’23: $6MQ2 ’23Q3 ’23: $6MQ3 ’23Q4 ’23: $7MQ4 ’23Q1 ’24: $7MQ1 ’24Q2 ’24: $7MQ2 ’24Q3 ’24: $8MQ3 ’24filingsflow.com
QuarterSharesValue% of Portfolio
Q3 202487.8K$8M+2.15%
Q2 202487.8K$7M+1.37%
Q1 202487.8K$7M+1.41%
Q4 202387.8K$7M+2.03%
Q3 202387.8K$6M+2.55%
Q2 202387.8K$6M+2.18%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Artia Global Partners LP’s full portfolio or all institutional holders of AXSM.